Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 3256 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

FDA approves Third Wave’s molecular test

The test simultaneously detects and identifies cystic fibrosis (CF) mutations in patient DNA samples. The InPlex CF Molecular Test delivers the accuracy of Third Wave’s Invader chemistry in

Greer initiates Phase III allergy trial

The trial is being conducted at 30 allergy specialty centers across the US and will enroll approximately 458 patients. Participants must be ages 18-50 and have a history